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AP-1 in cultured mesangial and mononuclear cells
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Angiotensin III increases MCP-1 and activates NF-kB and binding sites, are present in the kidney [1]. Among these
AP-1 in cultured mesangial and mononuclear cells. peptides, Ang II has been considered the effector of this
Background. Monocyte infiltration is a common feature of system, with an active role in the progression of renalrenal diseases. Angiotensin II (Ang II) participates in inflam-
damage [2, 3]. However, some of its degradative metabo-matory cell infiltration in the kidney. However, the influence
lites, such as Ang III, also possess potential biologicalof other peptides of the renin-angiotensin system, such as the
N-terminal Ang II degradation product Ang III, has not been activity [4]. Ang III, or des[Asp1]Ang II, is a heptapep-
addressed. tide produced from Ang II by cleavage of the NH2-Methods. In cultured renal and mononuclear cells, we inves- terminal aspartate group by the zinc metalloproteasetigated whether Ang III is involved in monocyte recruitment
aminopeptidase A (APA; EC.3.4.11.7) [5]. Ang III pre-through the regulation of the chemokine, monocyte chemoat-
sents some similar functions to Ang II, and thus, bothtractant protein-1 (MCP-1; Northern blot, Western blot, immu-
nofluorescence, and chemotaxis), and the activation of tran- peptides participate in cardiovascular and renal functions,
scription factors, nuclear factor kB (NF-kB) and activating stimulating the production of aldosterone and decreasing
protein-1 (AP-1; electrophoretic mobility shift assay).
renal blood flow and renin secretion [5–11]. Ang III alsoResults. In cultured rat mesangial and mononuclear cells,
plays a major role in brain physiology, regulating waterAng III increased MCP-1 gene expression and protein levels.
Supernatants from Ang III-treated mesangial cells showed in- homeostasis, blood pressure, and norepinephrine release
creased chemoattractant activity for monocytes, which was par- [5–11]. Some of the Ang II actions seem to be due to
tially inhibited by the addition of anti–MCP-1 antibody. Ang III Ang III. In this sense, vasopressin release depends on
elicited a rapid NF-kB activation (8-fold, after 30 min), showing
the prior conversion of Ang II to Ang III [12]. However,a kinetics and intensity similar to that observed with Ang II
whether this Ang-degradation product plays an activeand tumor necrosis factor-a. The maximal NF-kB activation
was correlated with nuclear translocation of p50 and p65 sub- role in pathological processes remains to be established.
units and disappearance of cytosolic IkB. Ang III also activated In the kidney, Ang II can be converted to Ang III by
AP-1 (5-fold, after 18 h), while SP-1 was unchanged. Two the APA found in glomeruli (podocytes and mesangialNF-kB inhibitors abolished the Ang III-induced MCP-1
cells) and in the brush border membrane of proximalmRNA expression, suggesting that overexpression of this che-
tubules [13–16]. Elevated renal APA has been found inmokine is mediated, at least in part, by NF-kB activation.
Conclusions. Ang III activates the transcription factors the glomeruli of diabetic rats, in hypertensive rats, and
NF-kB and AP-1 and increases the expression of related genes, after systemic Ang II infusion [17–19]. Ang II can also
such as MCP-1. Our study describes a novel and potent proin- be degraded by nonspecific peptidases present in highflammatory action of this Ang degradation product, expanding
density in the proximal tubuli [1], and for this reason,the present view of the renin-angiotensin system.
the tubular Ang II concentration is approximately 5 to
15% of total renal angiotensins [20]. All of these data
support the idea of the presence of angiotensin degrada-All components of the renin-angiotensin system, in-
tion products in the kidney in normal and pathologicalcluding those required for the formation and degradation
conditions.of angiotensins (Angs), as well as their specific receptor
Emerging evidence indicates that Ang III could partic-
ipate in the pathogenesis of renal damage. Renal infusion
Key words: monocyte chemoattractant protein-1, activating protein-1,
of Ang III into rats caused proteinuria [21], and in cul-inflammation, kidney, Ang III, renin-angiotensin system, nuclear fac-
tor-kB. tured renal cells, Ang III increased transforming growth
factor-b (TGF-b) mRNA expression and matrix proteinsReceived for publication August 6, 1999
production [22]. One of the new mechanisms of Ang IIand in revised form November 12, 1999
Accepted for publication January 14, 2000 action during renal damage is its role in mononuclear
cell recruitment through chemokine regulation [23]. Ele-Ó 2000 by the International Society of Nephrology
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vated levels of chemokines have been found in several with 100 U/mL penicillin, 100 mg/mL streptomycin, and
2 mmol/L glutamine in the presence of 10% fetal calfkidney diseases, and a major factor contributing to devel-
opment and progression of renal damage is the infiltra- serum (FCS) and cultured at 378C in a 5% CO2 atmo-
sphere. Glomerular mesangial cells were characterizedtion of the kidney by monocytes [24]. Monocyte chemo-
attractant protein-1 (MCP-1) is the main chemokine by phase contrast microscopy, positive staining for des-
min and vimentin, and negative staining for keratin andinvolved in this process [25–27]. We have recently shown
that Ang II increases MCP-1 in mesangial and mononu- factor VIII antigen, excluding epithelial and endothelial
contamination, respectively [35]. U937 cells (humanclear cells by a mechanism dependent on nuclear factor
kB (NF-kB) activation [23, 28]. Although Ang II acti- monocyte cell line; ATCC:CRL1593; American Type
Culture Collection, Rockville, MD, USA) and THP-1vates monocytes/macrophages under certain circumstances
[29, 30] and Ang III can be chemoattractant for poly- cells (human monocyte cell line, ATCC:TIB202) were
cultured in suspension in RPMI medium with 10% FCS.morphonuclear neutrophils [31], it is unclear whether
Ang III can affect monocyte-mediated inflammatory re- NRK 49F cells (rat kidney fibroblasts; ATCC:CRL1570)
were grown in DMEM with 5% FCS [22]. For all studies,sponses directly or indirectly by stimulating renal cells.
For this reason, we investigated whether Ang III could cultured rat mesangial cells were growth arrested by
0.5% FCS medium for 48 hours, and the cell lines werecontribute to the accumulation of inflammatory cells in
the kidney. First, we evaluated whether Ang III regulates serum starved.
the chemoattractant factor MCP-1 in resident renal and
RNA isolation and Northern blotmononuclear cells. Since the expression of many genes
associated with inflammation and renal damage is con- Mesangial cells were grown in 75 cm2 Petri dishes. For
the experiments with U937 cells, 5 3 106 cells were used.trolled by the activation of the transcription factors
NF-kB and activating protein-1 (AP-1) [32–34], and to After the incubation period, total RNA was extracted
by the Chomczynski and Sacchi method and quantitatedinvestigate further the molecular signals elicited by Ang
III, we also examined whether Ang III activates those by absorbance at 260 nm [36]. Northern blot analysis
was performed as previously described [23]. Blots werenuclear factors.
prehybridized for four hours at 428C in hybridization
solution [50% formamide, 1% sodium dodecyl sulfate
METHODS
(SDS), 5 3 standard saline citrate (SSC), 1 3 Denhardt’s
Antibodies and reagents solution, 0.25 mg/mL denatured salmon sperm DNA and
50 mmol/L sodium phosphate buffer, pH 6.5], and hy-All culture reagents were purchased from GIBCO
BRL (Paisley, Scotland, UK). a-[32P]dCTP (3000 Ci/ bridization was carried out at 428C overnight with 20%
dextran sulfate and a-[32P]–denatured probe. The filtersmmol) and g-[32P]CTP (3000 Ci/mmol) were from Amer-
sham (Buckinghamshire, UK). NF-kB and AP-1 consen- were washed using 2 3 SSC, 0.1% SDS, at room tempera-
ture for 30 minutes and then twice with 0.2 3 SSC, 0.1%sus oligonucleotides were from Promega Corp. (Madi-
son, WI, USA). The antibodies to NF-kB proteins (p65, SDS, at 558C for 15 minutes. Results were expressed as
arbitrary densitometric units relative to G3PDH.c-Rel and IkB/MAD-3) were from Santa Cruz Biotech-
nology Inc. (Santa Cruz, CA, USA) and p50 from Chemi-
Chemotaxis assaykon (Temecula, CA, USA). Rabbit polyclonal antirat
MCP-1 antibody was from Peprotech EC Ltd. (London, Quiescent confluent mesangial cells were stimulated
for 18 hours with Ang II, Ang III, and tumor necrosisUK). Recombinant MCP-1 and anti-human MCP-1 anti-
body were from Immugenex Corp. (Los Angeles, CA, factor-a (TNF-a) as a positive control. The chemoattrac-
tant activity of mesangial cells supernatants was evalu-USA). Secondary horseradish peroxidase (HPO)-conju-
gated and fluorescein isothiocyanate (FITC)-labeled an- ated in 24-well Transwell chemotaxis chamber (5 mm
pore size; Costar, Cambridge, MA, USA) as previouslytibodies were from The Binding Site Inc. (Birmingham,
UK). All other chemicals were from Sigma Chemical described [37]. Previous works have studied the migra-
tion of monocyte cell lines, THPs, MonoMac-6, and(St. Louis, MO, USA). None of the compounds were
cytotoxic for mesangial cells at the concentrations used, U937, showing that only THPs and MonoMac-6 respond
to betachemokines, while U937 failed to respond to anyas determined by trypan blue staining (data not shown).
member of this subfamily, including MCP-1 [38]. For
Cell cultures this reason, we chose the THPs cell line to investigate
whether after Ang III stimulation mesangial cells couldRat mesangial cells were cultured from isolated glo-
meruli by several sieving techniques and differential cen- produce chemoattractant factors, particularly MCP-1.
Upper chambers were loaded with 2.5 3 105 monocytestrifugation by a standard method in our laboratory [23].
Mesangial cells were grown in RPMI 1640 medium buf- (THP cell line). The lower wells were loaded with 500 mL
of supernatants, buffer alone, or MCP-1 and were coveredfered with 25 mmol/L HEPES at pH 7.4 supplemented
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with 5 mm pore size polycarbonate membrane. Plates Electrophoretic mobility shift assays (EMSAs)
were incubated for one hour at 378C to allow transmigra- Transcription factor activities were determined as pre-
tion. Migrating cells in the lower part were counted by viously described [23, 28]. Briefly, NF-kB and AP-1
flow cytometry. Rat recombinant MCP-1 (100 ng/mL) consensus oligonucleotides (59-AGTTGAGGGGAC
was employed as positive chemoattractant. Specific che- TTTCCCAGGC-39 and 59-CGCTTGATGAGTCAG
motaxis represents the average number of migrated cells CCGGAA-39, respectively) were [32P] end-labeled with
minus the mean number of cells migrating in the buffer g-[32P]ATP and T4 polynucleotide kinase (Promega).
alone related to total cells in the upper chamber. Ran- Nuclear extracts (5 to 10 mg) were equilibrated for 10
minutes in a binding buffer [4% glycerol, 1 mmol/Ldom migration was calculated as the migrating cells in
MgCl2, 0.5 mmol/L EDTA, 0.5 mmol/L DTT, 50 mmol/Lbuffer alone in relationship to total cells in the upper
NaCl, 10 mmol/L Tris-HCl, pH 7.5, and 50 mg/mL ofchamber and represents in these experiments less than
poly(dI-dC); Pharmacia LKB, Uppsala, Sweden], and1% of total cells added to the top chambers. Chemotaxis
then the labeled probe (0.35 pmol) was added and incu-versus chemokinesis was done to determine gradient-
bated for 20 minutes at room temperature. To establishdirect cell movement versus increased random cell move-
the specificity of the reaction, negative controls withoutment by a modified checkerboard analysis [39]. In these
cellular extracts and competition assays with a 100-foldexperiments, MCP-1 and mesangial cell-conditioned su-
excess of unlabeled, mutant, and unrelated oligonucleo-pernatant were added to both the upper and lower wells
tides were done. In competition assays, the unlabeledto disrupt the chemoattractant gradient (data not
probe was added to the reaction mixture 10 minutesshown). Neutralizing experiments were done with condi-
prior to the addition of the labeled probe. Hela celltioned supernatants preincubated with 1 mg/mL antibody
nuclear extract was used as a positive control of theagainst rat MCP-1 at 378C for one hour. These results
technique (data not shown). For supershift assays, 1 mgare expressed as the percentage of increase versus un-
of antibodies was added and incubated with nuclear ex-
stimulated cells or as the percentage of inhibition versus tracts for one hour prior to the addition of labeled probe.
conditioned supernatants without antibody. Direct che- The specificity of these antibodies was tested by Western
motaxis of Ang peptides was also evaluated in THPs blot (data not shown). The reaction was stopped by add-
cells. The stimuli (Ang III, Ang II, and MCP-1) were ing gel loading buffer (250 mmol/L Tris-HCl, 0.2% bro-
resuspended in serum-free RPMI, placed into lower mophenol blue, 0.2% xylene cyanol, and 40% glycerol)
chambers, and incubated for one, two, and four hours. and run on a nondenaturing 4% acrylamide gel in Tris-
Results are expressed as the number of migrating cells/ Borate. The gel was dried and exposed to x-ray film.
well, and control was considered as buffer alone (RPMI).
Western immunoblot analysisChemoattractant assays were independently performed
three times for each experiment. For MCP-1 determination, resting U937 cells were
incubated for 24 hours with 1027 mol/L Ang III and
Preparation of nuclear and cytosolic extracts 100 U/mL TNF-a used as positive control. Then, the
conditioned media was isolated, concentrated 10 timesNuclear and cytosolic extracts were obtained as pre-
by centrifugation using ultra-free MCt filters, and keptviously described [23, 28]. After the incubation period,
at 2208C until analysis. For IkB detection, cytosolic frac-mesangial cells were trypsinized and resuspended in
tions (40 mg) were obtained as described previously inbuffer A [10 mmol/L HEPES, pH 7.8, 15 mmol/L KCl,
this article. The samples were separated by SDS-poly-2 mmol/L MgCl2, 0.1 mmol/L ethylenediaminetetraacetic
acrylamide gel electrophoresis (PAGE) and electropho-acid (EDTA), 1 mmol/L dithiothreitol (DTT), and 1
retically transferred to polyvinylidene difluoride mem-mmol/L phenylmethylsulfonyl fluoride (PMSF)] and
branes (Millipore, Bedford, MA, USA). Membraneswere homogenized. Nuclei and cytosolic fractions were
were blocked in 0.1 mmol/L Tris, pH 7.5, and 0.1 mmol/Lseparated by centrifugation at 1000 3 g for 10 minutes.
NaCl containing 0.1% Tween-20, 1% bovine serum albu-The cytosolic fractions (supernatant) were stored at
min (BSA) and 5% dry skim milk for 30 minutes at 378C,
2808C until IkB analysis. The nuclei (pellet) were and then incubated in the same buffer with anti–MCP-
washed twice in buffer A and resuspended in the same 1 or anti-IkB/MAD-3 antibody for 18 hours at 48C. After
buffer, with a final concentration of 0.39 mol/L KCl. washing, detection was made by incubation with peroxi-
Nuclei were extracted for one hour at 48C and centrifuged dase-conjugated secondary antibody and developed us-
at 100,000 3 g for 30 minutes. Supernatants were dialyzed ing an enhanced chemiluminiscence kit (ECL; Amer-
in buffer C (50 mmol/L HEPES, pH 7.8, 50 mmol/L KCl, sham).
10% glycerol, 1 mmol/L PMSF, 0.1 mmol/L EDTA, and
Immunofluorescence staining1 mmol/L DTT) and then cleared by centrifugation and
stored at 2808C. The protein concentration was deter- Mesangial cells were grown in eight-well Titer-Tek
slides (Costar). To study NF-kB proteins, quiescent cellsmined by the bicinchoninic acid (BCA) method.
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were incubated with 1029 mol/L Ang III, Ang II, and tensity and kinetics to that of Ang II and TNF-a (Fig.
1A) [23, 25]. Treatment of resting human mononuclear100 U/mL TNF-a for 30 minutes. After incubation, cells
were washed, fixed in methanol/acetone at 2208C for 20 cells (U937 cell line) with Ang III for six hours also
increased MCP-1 gene expression (1027 mol/L, 3.6-fold,minutes, and then treated with 3% paraformaldehyde
for 10 minutes on ice and afterwards with 0.1% Triton- N 5 3, P , 0.05; Fig. 1B). By contrast, in renal interstitial
fibroblasts (NRK49 cell line), neither Ang III nor Ang IIX100 for 1 minute on ice to permeabilize nuclear mem-
branes. Cells were incubated with 10% goat serum in increased MCP-1 gene expression at the times studied
(Fig. 1C), while this gene was up-regulated by 10 U/mLPBS for one hour at 378C. Rabbit polyclonal antibodies
against p50 and p60 subunits (10 mg/mL) were used as IL-1b (4-fold, N 5 3, P , 0.05), as previously shown [27].
To determine whether the increase of MCP-1 expres-primary antibody, and a 1/200 dilution of FITC-labeled
goat antirabbit IgG was used as a secondary antibody. sion in response to Ang III is associated with protein
production, MCP-1 synthesis was determined by indirectFor MCP-1, cells were stimulated for six hours and fixed
in methanol/acetone at 2208C. A polyclonal antibody immunofluorescence microscopy analysis with polyclonal
anti–MCP-1 antibody in mesangial cells. Control cellsagainst rat MCP-1 (10 mg/mL) was used as the primary
antibody and, after washing with PBS, a 1/200 dilution showed a minimal immunoreactivity for MCP-1 (Fig. 2A).
After six hours of stimulation with Ang III and Ang IIof FITC-labeled IgG was used as the secondary antibody.
Controls were stained with nonimmune serum or with (1027 mol/L), a higher cytoplasmic staining was observed,
showing an increase in MCP-1 production. The cyto-the secondary antibody alone. Preparations were mounted
in a 70% glycerol solution and examined under a micro- plasmic pattern was similar to that previously shown [40].
In control experiments with unrelated IgG, no stainingscope. Images were photographed and printed at equiva-
lent exposures. was detected (data not shown). We also determined
whether Ang III caused the release of MCP-1 in superna-
Statistical analysis tants of U937 cells. Cells were incubated for 24 hours
with 1027 mol/L Ang II and Ang III, and 100 U/mL TNF-aAutoradiograms were scanned using the Image Quant
densitometer (Molecular Dynamics, Sunnyvale, CA, (positive control), and MCP-1 synthesis was determined
by Western blot. After treatment with Ang III, Ang II,USA). Results are expressed as arbitrary densitometric
units as N-fold over control and are expressed as the or TNF-a, a marked increased in MCP-1 release was
observed (Fig. 2B). The MCP-1 was detected as a bandmean of the experiments made. Significance was estab-
lished using a Student’s t-test and analysis of variance. of 12 to 14 kD, similar to that of the recombinant MCP-1.
To investigate whether Ang III could induce produc-Differences were considered significant if the P value
was less than 0.05. tion of biologically active chemoattractant factors, quies-
cent mesangial cells were stimulated for 18 hours with
1027 mol/L Ang III, Ang II, and 100 U/mL TNF-a, and
RESULTS
the chemoattractant activity of tissue culture supernatants
Ang III increases MCP-1 in cultured glomerular was tested. Mesangial cells produce a basal level of mono-
mesangial cells and mononuclear cells cyte chemoattractant activity, which was significantly in-
creased by Ang III, Ang II, and TNF-a (N 5 5, P , 0.05Monocyte chemoattractant protein-1 is the main che-
mokine involved in monocyte/macrophage infiltration in vs. control; Fig. 3A); similar results were observed in
human mesangial cells stimulated with proinflammatorythe kidney [24–26]. Several renal cells can produce MCP-1
upon appropriate stimulation, including cytokines and cytokines [39, 40]. Recombinant rat MCP-1 was used as
positive chemoattractant control for THPs (Fig. 3). Me-Ang II [23–27]. To determine whether the degradation
peptide Ang III could directly increase MCP-1 mRNA, dium alone (RPMI) had no effect on the migration of these
cells (Fig. 3). To investigate whether the Ang-inducedserum-starved mesangial cells, mononuclear cells (U937
cell line), and renal interstitial fibroblasts (49F cell line) monocyte migration was due to MCP-1, neutralizing ex-
periments were done. We have used 10 mg/mL antiratwere incubated in serum-free medium with Ang III and
Ang II (1027 to 1029 mol/L) for increasing periods of MCP-1 antibody that inhibited the biological chemoat-
tractant activity of 100 nmol/L rat MCP-1 (97% inhibi-time, and MCP-1 mRNA expression was determined by
Northern blot. TNF-a (100 U/mL) and IL-1b (10 U/mL) tion). Treatment of supernatants from Ang III and Ang II-
treated mesangial cells reduced the migration (approxi-were used as positive controls [23, 27]. Quiescent mesan-
gial cells presented basal levels of MCP-1 gene expres- mately 40% inhibition) to values close to unstimulated
mesangial cells (Fig. 3B). The specificity was determinedsion (Fig. 1A). Ang III stimulation increased MCP-1
mRNA levels as early as at three hours, being maximal by incubation with an unrelated IgG (less than 5% inhibi-
tion). These results suggest that Ang III could play aat six hours (1029 mol/L, 5-fold vs. control, N 5 5, P ,
0.05) and diminished after 24 hours (Fig. 1A). The Ang III- role in inflammatory conditions through the production
of biologically active MCP-1 by resident renal cells. Di-induced MCP-1 gene up-regulation showed a similar in-
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Fig. 1. Monocyte chemoattractant protein-1
(MCP-1) gene expression in rat mesangial
cells (A), human mononuclear cells (B), and
rat interstitial fibroblasts (C ) stimulated with
angiotensin III (Ang III). (A) Quiescent cells
were incubated for 3, 6, and 24 hours with
Ang III and Ang II. (B) U937 and (C)
NRK49F cells were treated for six hours with
1027 mol/L Ang III and Ang II. One hundred
U/mL tumor necrosis factor-a (TNF-a) or 10
U/mL interleukin-1b (IL-1b) were used as
positive controls. MCP-1 (upper panels) and
G3PDH (middle) mRNA expression were de-
termined by Northern blot. A representative
autoradiogram from five (A) and three (B and
C) different experiments with identical results
is shown. Values of means 6 SEM obtained
by densitometric analysis are shown in the
lower panels. *P , 0.05 vs. control values.
rect chemotaxis of those Ang peptides in human mono- periods of time. After one hour, only 100 ng/mL rat
MCP-1 showed a significative chemoattractant responsenuclear cells was also tested. Stimuli (Ang III, Ang II,
and MCP-1) were resuspended in serum-free RPMI, (N 5 10, P , 0.005 vs. control), while at four hours,
a significant increase in monocyte migration was alsoplaced into lower chambers, and incubated for increasing
Fig. 2. (A) Localization of MCP-1 in mesangial cells. In control cells,
a slight cytoplasmatic immunostaining was seen with anti–MCP-1 anti-
body. When cells were treated for six hours with 1029 mol/L Ang III
and Ang II, an intense cytoplasmatic fluorescence was observed. These
data shown are representative of four experiments. (B) Secretion of
MCP-1 by U937 cells in response to Ang III. Cells were incubated in
medium alone or in the presence of 1027 mol/L Ang II, Ang III or 100
U/mL TNF-a for 24 hours. The supernatant was concentrated tenfold,
and MCP-1 synthesis was determined by Western blot analysis. Human
recombinant MCP-1 was used as a positive control. Results are from
one of two comparable series of experiments.
observed with 1027 mol/L Ang III and Ang II (N 5 5,
P , 0.05 vs. control; Fig. 3C), suggesting a potential direct
chemoattractant action in long-term exposure experi-
ments.
Fig. 3. (A) Chemoattractant activity of mesangial cells stimulated for
18 hours with Ang III, Ang II, and TNF-a. Recombinant rat MCP-1
Ang III activates NF-kB in cultured cells was used as positive control for migration. Results are expressed as the
number of migrating cells per well. *P , 0.05 vs. random migration;Nuclear factor-kB has been identified as an important P , 0.05 vs. unstimulated mesangial cells. (B) Anti–MCP-1 antibody
DNA-binding protein that initiates the transcription of was used to inhibit migration in supernatants from Ang III- and Ang
II-treated mesangial cells. Data are expressed as a percentage versusmany genes associated with renal damage, including
unstimulated mesangial cells and are means 6 SD of two experiments.MCP-1 [23, 33, 41, 42]. To map the intracellular signals #P , 0.05 absence vs. presence of anti-MCP-1 antibody. (C) Direct
emanating from Ang III, we evaluated the effect of Ang chemoattractant action of Ang III in human mononuclear cells. THPs
cells were stimulated for increasing periods of time with 1027 mol/LIII on NF-kB activity in cultured mesangial cells and
Ang III (X ), Ang II (d), and 100 nmol/L MCP-1 (r). Results are
mononuclear cells in comparison with Ang II. Growth- expressed as the number of migrating cells per well, and control was
considered as buffer alone (m), placed in the lower chamber.arrested mesangial cells were incubated with Ang III
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Fig. 4. Ang III activates nuclear factor–kB (NF-kB) DNA binding in mesangial cells. (A) Time course. Cells were incubated for 30, 60, and 120
minutes with 1027 mol/L Ang III and compared with Ang II and gel shift assay was performed. (B) Dose response. Cells were treated for 30
minutes with Ang III (1027 to 10210 mol/L). Representative autoradiograms of six different experiments with similar results are shown. The
specificity of the reaction was established using competition assays with a 100-fold excess of unlabeled NF-kB. The positions of the specific NF-kB
complexes and free-oligonucleotide are indicated. (C) Results of densitometric analysis for specific NF-kB binding activity are shown (means 6
SEM). *P , 0.05 vs. control values. (D) Role of amastatin (AMA) in NF-kB activation. Cells were preincubated for 30 minutes with AMA and
then stimulated with 1029 mol/L Ang II (D). Cells were also pretreated with (Sarl, Thr8)-angiotensin III (SAR; 1026 mol/L) and then stimulated
with Ang III for 30 minutes. A representative autoradiogram of three experiments is shown in the upper panel, and densitometric analysis as
means 6 SEM is shown in the lower panel. *P , 0.05 vs. control values; #P , 0.05 vs. Ang III-treated cells; $P 5 NS vs. Ang II.
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(1027, 1029, and 10211 mol/L) for 30, 60, and 120 minutes.
Nuclear extracts were obtained, and NF-kB activity was
determined by binding assay of nuclear proteins to an
oligoconsensus labeled with g-[32P]. Ang III caused a
dose- and time-dependent increase in NF-kB DNA-
binding activity, with an intensity and kinetics similar to
that previously observed with Ang II and TNF-a. The
maximal Ang III response was observed at 1029 mol/L
after 30 minutes (8-fold and 9-fold over basal values,
Ang III and Ang II, respectively, N 5 6, P , 0.05; Fig.
4). The reaction was proved to be specific since cold
NF-kB prevented the formation of the complexes that
contained the labeled NF-kB (as shown by a decrease
in the signal of 2 retarded bands).
Several studies have indicated that endogenous degra-
dative proteases may interfere with the quantitative eval-
uation of the effects of Ang peptides [43, 44]. Aminopep-
tidase A (APA) and M are expressed in mesangial cells
[15, 16]. Pretreatment with 1027 mol/L amastatin (AMA),
an APA and M inhibitor [14], for 30 minutes did not
modify Ang II-induced NF-kB activation (Fig. 4D). AMA
alone had no effect (data not shown). Our data show
Fig. 5. Ang III activates NF-kB DNA binding in mononuclear cells.
that in our culture conditions the Ang II effect did not U937 cells were stimulated with Ang III and Ang II (1027 to 1029 mol/L)
for increasing periods of times. TNF-a was used as a positive control.require previous conversion into Ang III. To determine
A representative autoradiogram of four different experiments withwhether Ang III-induced NF-kB activation was receptor
similar results is shown. The specificity of the reaction was established
dependent, cells were pretreated with a peptidic Ang III using competition assays with a 100-fold excess of cold NF-kB. Negative
control was done in the absence of nuclear extracts. The position ofanalogue (Sarl, Thr8)-Ang III (SAR; 1026 mol/L) and
the specific NF-kB complexes and free-oligonucleotide is indicated.then stimulated with Ang III for 30 minutes. As shown
in Figure 4D, an inhibition of NF-kB activation induced
by Ang III was noted, suggesting a receptor-mediated
response. effect (Fig. 6), and therefore, this subunit does not seem
We next studied the effect of Ang III in NF-kB activa- to be present in mesangial cells, as previously observed
tion in human mononuclear cells (U937 cell line). When
[23]. The bottom band contains p50 homodimers, which
quiescent mononuclear cells were stimulated with Ang II
have been found to be unable to activate transcription
or Ang III for 30, 60, and 120 minutes (1027 to 1029
in vivo, and the upper band is a heterodimer of p50/p65mol/L), a dose-dependent increase in NF-kB DNA-bind-
that confers inducible transcriptional activity of the -kBing activity was observed. This response was maximal
motifs in different cell types [46, 47]. By immunofluores-after 60 minutes with 1029 mol/L (3.0-and 3.1-fold over
cence, we have localized these NF-kB subunits in mesan-control, Ang III and Ang II, respectively, N 5 4, P ,
gial cells. In control cells, a diffuse cytoplasmic, but not0.05; Fig. 5).
nuclear, fluorescence was seen (Fig. 7). When cells were
treated with Ang III and Ang II (1029 mol/L) for oneCharacterization of the protein subunits involved in
hour, a clear nuclear staining pattern for p50 and p65Ang III-induced NF-kB activation
was noted (Fig. 7), indicating a nuclear translocation ofNuclear factor-kB is a complex of Rel-related factors
these NF-kB subunits. All of these data suggest thatbound to a member of proteins termed IkB, specific for
the NF-kB complex induced by Ang III consists of aneach cell type [45]. Nuclear extracts from Ang III-treated
heterodimer of p50 and p65 subunits. NF-kB activationmesangial cells yielded two specific bands in a mobility
occurs following dissociation of the inhibitory subunitshift analysis. The composition of these NF-kB–protein
IkB, which is degraded by a proteolytic process [45]. Next,complexes was analyzed using specific antibodies to vari-
we evaluated the effect of Ang III on cytosolic IkBaous members of the NF-kB/Rel family to supershift the
protein levels. Cytosolic extracts of mesangial cells wereDNA protein complexes. Incubation of the nuclear extracts
immunoblotted for IkBa. In control cells, IkBa was foundfrom Ang III-stimulated cells for one hour with 1 mg of
as a protein of around 37 kD. After Ang III stimulationanti-p50 and anti-p65 antibodies caused the appearance
this band rapidly disappeared, suggesting IkBa degrada-of slower migration complexes (labeled shifted com-
plexes; Fig. 6). The antibody against c-Rel was without tion (Fig. 8). The time course of Ang III-induced IkBa
Ruiz-Ortega et al: Proinflammatory action of Ang III 2293
Fig. 6. Determination of NF-kB subunits in Ang III-
treated mesangial cells. The nuclear extracts were
preincubated with antibodies against the subunits
p50, p65, and c-Rel and were then analyzed for
NF-kB binding activity. Supershifted bands were ob-
served with anti-p50 and anti-p65 antibodies (marked
by arrows). The specificity of the reaction was estab-
lished using competition assays with a 100-fold excess
of unlabeled NF-kB (specific competitor), mutant
NF-kB, and unrelated (AP-1) oligonucleotide.
Fig. 7. Localization of NF-kB subunits in mesangial cells. In control cells a diffuse cytoplasmatic immunostaining was seen with anti-p50 and anti-
p65 antibodies. When cells were treated for one hour with 1029 mol/L Ang II and Ang III, an intense nuclear fluorescence was observed with
both antibodies, showing a translocation of the p50 and p65 subunits into the nuclei.
degradation was closely correlated with the maximal
NF-kB activation and with the translocation of p50 and
p65 subunits to the nuclei.
Ang III increases MCP-1 mRNA expression through
NF-kB activation in mesangial cells
Monocyte chemoattractant protein-1 is regulated at
the transcription level by NF-kB [41, 42]. To investigate
whether the Ang III-induced MCP-1 overexpression was
mediated by NF-kB, we have used two inhibitors, the
pyrrolidine dithiocarbamate (PDTC), which has been
shown to block cytokine, Ang II, and phorbol ester-
induced NF-kB activation in several cell lines [23, 41],
and the specific reversible inhibitor of the proteasome Fig. 8. Ang III reduces IkBa levels in mesangial cells. Cells were
treated with 1029 mol/L Ang III and Ang II for 30 and 60 minutes.N-cbz-Leu-Leu-leucinal (MG-132) [48]. Treatment of
Cytosolic extracts were electrophoresed under reducing, denaturingmesangial cells with PDTC and MG-132 inhibited Ang III-
conditions, stained with affinity-purified anti-IkBa antibody (apparent
induced NF-kB activation, as shown by the diminution molecular mass of 37 kD), and visualized by enhanced chemiluminis-
cence. This is representative of three experiments with identical results.of the intensity of the two bands (Fig. 9A). PDTC caused
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Fig. 9. Effect of pyrrolidine dithiocarbamate
(PDTC) and N-cbz-Leu-Leu-leucinal (MG-132)
in Ang III-induced NF-kB binding activity (A).
Cells were preincubated with PDTC and MG-
132 (1025 mol/L) for one hour and then stimu-
lated with 1029 mol/L Ang III for 30 minutes.
A representative EMSA of two different ex-
periments with similar results is shown in the
upper panel. The results of densitometric anal-
ysis of the upper band, corresponding to the
p50/p65 heterodimer, are shown in the lower
panel (means). (B) The effect of PDTC and
MG-132 in Ang III-induced MCP-1 mRNA
expression in mesangial cells. Cells were pre-
incubated with PDTC and MG-132 (1025 mol/L)
for one hour and then stimulated with 1029
mol/L Ang III for six hours. A representative
Northern blot of two made, corresponding to
hybridization with MCP-1 (upper panel) and
G3PDH (middle) from two different experi-
ments with identical results, and values of den-
sitometric analysis (lower panel) are shown.
a marked decrease in the upper band, corresponding mol/L Ang II, 4-fold; Fig. 10A). In mononuclear cells,
to the p50/p65 heterodimer that has been involved in Ang III also significantly increased AP-1 DNA binding
transcriptional activation [47]. The preincubation of mes- activity after 18 hours (4.5-, 2.5-, and 10-fold, 1027 mol/L
angial cells with PDTC and MG-132 (1025 mol/L) for Ang II, Ang III, and PMA, respectively, N 5 4; Fig. 10B).
one hour abolished the Ang III-increased MCP-1 mRNA An excess of unlabeled AP-1 consensus oligonucleotide
levels, which correlated with the inhibition of both com- prevented the formation of the complex with the labeled
pounds of Ang III-induced NF-kB activation (Fig. 9). probe, indicating the specificity of the AP-1 binding ac-
These data suggest that the increase in MCP-1 mRNA tivity (Fig. 10B). As an additional negative control, the
expression elicited by Ang III in mesangial cells is, at binding reaction was done in the absence of nuclear
least in part, NF-kB mediated. extracts (Fig. 10B). As a positive control, Hela nuclear
extracts were used (data not shown). By contrast, in our
Ang III activates AP-1 but not SP-1 transcription culture conditions, neither Ang III nor Ang II increased
factor in cultured cells SP-1 DNA binding activity (data not shown).
The regulation of MCP-1 gene is also controlled by
the transcription factor Sp-1, responsible for the mainte-
DISCUSSIONnance of basal transcription [42], and by AP-1, as shown
The recruitment of monocyte-macrophages in the kid-in cytokine-treated endothelial cells [49]. Previous stud-
ney, due to the release of chemoattractant factors byies have demonstrated that in vivo Ang II infusion in-
resident and infiltrating cells, is an important fact in thecreases renal AP-1 activity, but has no effect on SP-1
induction and progression of renal injury [24]. MCP-1 is[50]. Growth-arrested cells were incubated with Ang III
overexpressed during renal damage in settings associatedand Ang II (1027, 1029, and 10211 mol/L) for increasing
to activation of the local renin-angiotensin system, asperiods of time. PMA (1027 mol/L) and TNF-a (100 U/mL)
well as in target organs of hypertensive rats [23, 51, 52].were used as positive controls [34]. Nuclear extracts were
Moreover, treatment of nephritic rats with anti–MCP-1obtained, and AP-1 and SP-1 DNA binding activity was
antibodies diminished glomerular monocyte infiltrationdetermined by EMSA. In mesangial cells, Ang III in-
[53]. In this article, we have demonstrated that in culturedcreased AP-1 DNA binding activity after four hours; the
glomerular mesangial and mononuclear cells, Ang IIIoptimal induction was found after 18 hours (1027 mol/L;
caused a marked increase in MCP-1 mRNA expression3.2-fold vs. control, N 5 5, P , 0005) and declined at
and synthesis, with similar intensity and kinetics to in-24 hours (Fig. 10A). We have observed that the Ang III
flammatory cytokines and Ang II. In addition, Ang III-effect was lower in intensity and kinetics than Ang II,
which presented its maximal response at 24 hours (1027 conditioned mesangial cell supernatants caused mono-
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Fig. 10. Ang III activates AP-1 in mesangial (A and B) and mononu-
clear cells (C ). (A) Mesangial cells were incubated for 4, 18, and 24 hours
with 1027 mol/L Ang III and Ang II. A representative autoradiogram of
five different experiments with similar results is shown (A). Values of
means 6 SEM obtained by densitometric analysis are shown in (B).
*P , 0.05 vs. control values. (C) U937 cells were stimulated for 18
hours with 1027 mol/L Ang III and Ang II. This shows a representative
experiment of a total of four. As a positive AP-1 activator, 1027 mol/L
PMA was used. Negative control was done in the absence of nuclear
extracts. The specificity of the reaction was established using competi-
tion assays with a 100-fold excess of unlabeled AP-1 oligonucleotide.
The position of the specific AP-1 complexes and free oligonucleotide
is indicated.
cyte migration that was partially diminished by anti– Most of the Ang III studies are descriptive, evaluating
mostly physiological functions such as drinking behaviorMCP-1 antibody. In endothelial cells, Ang II elicited the
synthesis of other chemoattractant factors, as RANTES and blood pressure, and only a few transmembrane signal-
ing mechanisms have been investigated. Ang III increasedand a neutrophil chemoattractant [54, 55], showing that
the remaining migratory activity is presumably caused intracellular calcium, inositol phosphate production, and
c-fos mRNA expression [22, 57, 58]. An important eventby the presence of other chemokines in the supernatants.
Previous studies have shown that circulating cells possess in signal transduction mechanisms is the activation of
nuclear transcription factors. We have observed that inreceptors for Ang III and Ang II [56], and some evidence
exists that Ang III presents chemoattractant activity for mesangial and mononuclear cells, Ang III activates two
transcription factors, NF-kB and AP-1, which regulatepolymorphonuclear neutrophils [31], but chemoattrac-
tion for monocytes/macrophages has not been tested. As the expression of genes encoding proteins involved in
inflammatory response and renal injury [32–34, 42, 49],described in our article, in long-term exposure experi-
ments, Ang III and Ang II are weak chemoattractant suggesting that Ang III through transcription factor modu-
lation could be potentially involved in tissue damage.agents for monocytes/macrophages. Therefore, all of
these results strongly suggest that Ang III, mainly via Nuclear factor-kB is a transcription factor activated
by several stimuli, including cytokines, growth factors,MCP-1 production by resident renal and infiltrating cells,
as well as via direct chemotaxis, may play a role in the and Ang II [23, 40, 41]. We have shown that in cultured
mesangial and mononuclear cells, Ang III activates NF-kBregulation of monocyte recruitment in the kidney.
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DNA binding as early as at 30 minutes, with a similar Ang III response was 10 times less potent than Ang II
potency and kinetics to that of Ang II and TNF-a. The [6, 21]. Our studies, comparing the effect of both peptides
NF-kB complex activated by Ang III is a heterodimer in the same culture conditions, showed a similar potency
of p50 and p65 subunits, as indicated by mobility supershift and kinetics in NF-kB activation and MCP-1 gene ex-
assay. In unstimulated cells, NF-kB is found in a latent pression, although the effect of Ang III in AP-1 activa-
form in the cytoplasm and stabilized by the inhibitor tion was weaker and shorter than Ang II. Although many
subunit IkB [45]. After Ang III stimulation, there was studies have been done regarding the intracellular signals
a translocation of p50 and p65 subunits from the cyto- elicited by Ang II, little information on Ang III signals
plasm to the nuclei, correlated with disappearance of cyto- is available.
solic IkBa. The active nuclear NF-kB complexes induced In conclusion, our data suggest that in renal diseases
by Ang III could bind to specific DNA sequences and characterized by increased local Ang II generation and
increase the transcription of related genes. NF-kB plays protease activity, the degradation products of Ang II,
an important role in the regulation of the expression of particularly Ang III, could also play an active role in the
proinflammatory genes, such as chemokines and adhe- recruitment of mononuclear cells by a process mediated
sion proteins [32, 33]. Elevated levels of renal NF-kB by the regulation of the chemokine MCP-1 and the tran-
activity have been found in experimental models of ne- scription factors NF-kB and AP-1. On the whole, our
phritis [23, 59, 60], and after systemic Ang II infusion study further supports the new view of the renin-angioten-
(abstract; Ruiz-Ortega et al, Am J Hypertens 12:25A, sin system: that other peptides besides Ang II could partic-
1999). This increase in NF-kB activity was well correlated ipate in the initiation and progression of kidney damage.
with mononuclear cell infiltration and renal expression
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